<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT943-8213</title>
	</head>
	<body>
		<main>
			<p>940818 FT  18 AUG 94 / UK Company News: British Biotech director's pay up Mr Keith McCullagh, chief executive of British Biotech, saw his total emoluments, excluding pension contributions, increase by 18.8 per cent from Pounds 191,000 to Pounds 227,000 last year even though the group's pre-tax loss widened from to Pounds 21.5m from Pounds 13.1m. Mr McCullagh, one of the founders of the company in 1986, also benefited from increased pension contributions of Pounds 17,000 (Pounds 12,000). When British Biotech announced the higher loss for the year to April 30, it emphasised that it had been another successful year for the group.</p>
		</main>
</body></html>
            